Consensus IDEXX Laboratories, Inc.

Stocks

IDXX

US45168D1046

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 02:30:00 14/11/2026 am IST			5-day change	1st Jan Change
704.23 ^USD	+0.89%		+5.00%	+4.09%

12/11	IDEX Keeps Quarterly Dividend at $0.73 per Share, Payable Jan. 27, 2027, to Holders of Record Jan. 13	MT
05/11	Rising vet bills drive more Americans to pet insurance	RE

Evolution of the Average Target: IDEXX Laboratories, Inc.

Evolution of the Target Price: IDEXX Laboratories, Inc.

Changes in Analyst Recommendations: IDEXX Laboratories, Inc.

9d.AfS1wdIdtaEx8rjM-W49G6DOTwNzVJgfNTgp39tsI-c.aYSE8uJq-MMGgeu-kD94a-isBHU9FfMtWVJbjb8Dd6E3nPLxuH7D8Xmk1w~2fde2d5daab73ab6fedaeb1e990663b3

Analysts' recommendations: IDEXX Laboratories, Inc.

04/11	Rothschild & Co Redburn Adjusts Price Target on IDEXX Laboratories to $700 From $665	MT
03/11	IDEXX Laboratories Delivered Strong Results Despite Lackluster Vet Visit Backdrop, UBS Says	MT
03/11	IDEXX Laboratories' Q3 Results Reflect Ability to Sustain Robust Pricing Despite Lower Vet Visits, UBS Says	MT
03/11	UBS Adjusts Price Target on IDEXX Laboratories to $700 From $627, Maintains Neutral Rating	MT
03/11	Goldman Sachs Adjusts Price Target on IDEXX Laboratories to $800 From $740	MT
02/11	Wall Street Picks Up the Pieces
27/10	UBS Adjusts IDEXX Laboratories Price Target to $627 From $670, Maintains Neutral Rating	MT
20/10	Jefferies Adjusts Price Target on IDEXX Laboratories to $705 From $795	MT
16/10	JPMorgan Adjusts Price Target on IDEXX Laboratories to $750 From $775	MT
12/10	KeyBanc Initiates IDEXX Laboratories at Sector Weight	MT
11/08	Barclays Adjusts Price Target on IDEXX Laboratories to $710 From $800, Keeps Overweight Rating	MT
05/08	Jefferies Adjusts Price Target on IDEXX Laboratories to $795 From $792	MT
05/08	Citigroup Adjusts Price Target on IDEXX Laboratories to $670 From $650	MT
05/08	UBS Adjusts Price Target on IDEXX Laboratories to $670 From $620, Maintains Neutral Rating	MT
27/07	Elanco Seems Best-Positioned Into Q2 Print Among Animal Health Stocks, UBS Says	MT
27/07	UBS Cuts IDEXX Laboratories Price Target to $620 From $640, Maintains Neutral Rating	MT
13/07	Leerink Partners Adjusts IDEXX Laboratories Price Target to $715 From $725, Maintains Outperform Rating	MT
06/05	Rothschild & Co Redburn Adjusts Price Target on IDEXX Laboratories to $665 From $655	MT
06/05	Jefferies Adjusts Price Target on IDEXX Laboratories to $792 From $785	MT
28/04	UBS Adjusts Price Target on IDEXX Laboratories to $640 From $730, Maintains Neutral Rating	MT
27/04	Jefferies Adjusts Price Target on IDEXX Laboratories to $785 From $820, Maintains Buy Rating	MT
15/04	Citigroup Initiates IDEXX Laboratories at Neutral With $650 Price Target	MT
14/04	Leerink Partners Adjusts IDEXX Laboratories PT to $725 From $760, Maintains Outperform Rating	MT
31/03	Stifel Nicolaus Adjusts IDEXX Laboratories PT to $675 From $775, Maintains Buy Rating	MT
09/02	Piper Sandler Adjusts Price Target on IDEXX Laboratories to $750 From $775, Maintains Neutral Rating	MT

More recommendations

Veterinary Medical Equipment & Supplies

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	IDEXX LABORATORIES, INC.					+2.74%
	ABBOTT LABORATORIES					+10.87%
	MEDTRONIC PLC					+3.97%
	STRYKER CORPORATION					+8.64%
	ESSILORLUXOTTICA					+20.02%
	CENCORA, INC.					+9.12%
	BECTON, DICKINSON AND COMPANY					+4.84%
	HOYA CORPORATION					+26.86%
	MEDLINE INC.					+13.42%
	ALCON INC.					+23.65%
	Average					+12.41%
	Weighted average by Cap.					+11.03%